More than a year ago, the World Health Organization (WHO) announced the Watson Clinic, an effort to expand the human-computer interaction (HCI) capabilities of doctors to provide faster diagnoses and more personalized care.
The new facility would also improve the ability to diagnose certain diseases using computer models.
The clinic is being operated by the Watson Health Group, a Boston-based company that also runs an in-house clinic that specializes in diagnosing and treating mental illness.
Watson Health’s website boasts that the clinic would provide “a faster and more accurate diagnosis for the thousands of people who need help in their everyday lives.”
The company’s CEO, Andrew J. Tarnopolsky, told investors this week that Watson is currently working on the Watson Healthcare Platform, a platform that would allow physicians to access Watson data in real time to diagnose and treat patients.
The company says that the platform will provide doctors with access to more information about their patients than they have ever had before.
Watson Healthcare says that its data will be available to doctors for up to one year after the Watson Platform is up and running.
The Watson Clinic has received approval to open its doors in Canada, but the company is still looking to expand its operations to other countries.
“As we continue to grow, we are also looking to partner with additional countries that can help us expand the capabilities of the Watson Care platform and make Watson accessible to the broader public,” Tarnapolsky said in a statement to the Globe.
Watson’s Watson Healthcare is also working on a platform called SmartBiotics that could offer “the first-ever access to the vast amount of data, insights, and data analysis available from Watson,” according to a company press release.
Watson and SmartBiotic are both based on Watson’s proprietary technology.
But Tarnopsky said that he believes Watson Healthcare’s technology is “much more advanced” than SmartBionic.
“I believe that we will be able to scale this [technology] much faster than it would take to build SmartBiotics, and we are confident that we can do it,” Tarsion said in an interview with the Globe and Mail.
Watson also recently unveiled a new version of its Watson Care Platform, called Watson Analytics, that it said would be the world’s “biggest” and “fastest-growing analytics platform,” according the company.
Watson Analytics will allow doctors to interact with patients’ data in a “very natural way” through interactive conversations, Tarsions said.
Watson CEO Andrew Tarnopolosky says Watson Healthcare will allow patients to interact “with their doctors in a natural way.”
(Watson/YouTube) Tarnopesky also said that Watson Healthcare plans to offer an app for doctors to make it easier to access their Watson data.
“It will be a much simpler, much more intuitive, much easier experience for doctors,” he said.
The partnership with Watson will be the first time that Watson has partnered with a healthcare company, according to the company’s press release, and Tarsorsky told the Globe that Watson’s partnership with the Watson Group will “enhance Watson’s ability to leverage Watson’s power in health care, helping doctors and patients to access data that is more relevant to their specific needs.”
Watson is still testing the technology in real-time, but Tarnope says that it has seen a large increase in patient requests for data in the last year.
“We’ve had a huge increase in demand, and that demand has grown dramatically,” Tarmopolski said.
“So we’re excited to be able provide it to doctors as soon as we can.”